Makes an argument in favour of federal pharamcare in Canada as opposed to provincial. The federal government has virtually all the regulatory tools, while the provinces are responsible for designing, administering, and funding their respective prescription drug subsidy plans.Alone, neither order of government is capable of addressing the financial sustainability problem or initiating thoroughgoing change in drug utilization patterns. Given the current stalemate, the time may have come to consider a more radical proposal in which one order of government assumes responsibility for prescription drug policy in Canada.
Greg Marchildon is currently Canada Research Chair in Public Policy and Economic History at the Johnson-Shoyama Graduate School of Public Policy, University of Regina. He is a senior fellow at the School of Policy Studies, Queen’s University, a mentor with the Trudeau Foundation, and the chair of the Saskatchewan Health Research Foundation. After receiving his PhD from the London School of Economics, he taught at the Johns Hopkins University School of Advanced International Studies in Washington. Dr. Marchildon served as cabinet secretary and deputy minister to the premier of Saskatchewan from 1996 to 2001. He was executive director of the Romanow Commission on the Future of Health Care. He is the author of Health Systems in Transition: Canada (University of Toronto Press, 2006) as well as other books and articles on Canadian health policy.